Torsten Engelbrecht works as a freelance journalist in Hamburg. He has written articles for publications such as Medical Hypotheses, British Medical Journal, Suddeutsche Zeitung, Neue Zurcher Zeitung, and The Ecologist. From 2000 to 2004, he worked as business editor of the Financial Times Deutschland.
Claus Kohnlein is a medical specialist of internal diseases. He completed this residency in the Oncology Department at the University of Kiel. Since 1993, he has worked in his own medical practice, treating Hepatitis C and AIDS patients who are skeptical of antiviral medications.
"How the Medical Industry Continually Invents Epidemics, Making Billion-Dollar Profits at our Expense"
Foreword by Etienne de Harven
The Content of this Book Has To Be Read, Quickly and Worldwide
The book Virus Mania by Torsten Engelbrecht and Claus Köhnlein presents a tragic message that will, hopefully, contribute to the re-insertion of ethical values in the conduct of virus research, public health policies, media communications, and activities of the
pharmaceutical companies. Obviously, elementary ethical rules have been, to a very dangerous extent, neglected in many of these fields for an alarming number of years.
When American journalist Celia Farber courageously published, in Harper’s Magazine (March 2006) the article “Out of control—AIDS and the corruption of medical science,” some readers probably attempted to reassure themselves that this “corruption” was an isolated
case. This is very far from the truth as documented so well in this book by Engelbrecht and Köhnlein. It is only the tip of the iceberg. Corruption of research is a widespread phenomenon currently found in many major, supposedly contagious health problems,
ranging from AIDS to Hepatitis C, Bovine spongiform encephalopathy (BSE or “mad cow disease”), SARS, Avian flu and current vaccination practices (human papillomavirus or HPV vaccination).
In research on all of these six distinct public health concerns scientific research on viruses (or prions in the case of BSE) slipped onto the wrong track following basically the same systematic pathway. This pathway always includes several key steps: inventing the risk of a
disastrous epidemic, incriminating an elusive pathogen, ignoring alternative toxic causes, manipulating epidemiology with non-verifiable numbers to maximize the false perception of an imminent catastrophe, and promising salvation with vaccines. This guarantees large
financial returns. But how is it possible to achieve all of this? Simply by relying on the most powerful activator of human decision making process, i.e. FEAR!
We are not witnessing viral epidemics; we are witnessing epidemics of fear. And both the media and the pharmaceutical industry carry most of the responsibility for amplifying fears, fears that happen, incidentally, to always ignite fantastically profitable business. Research
hypotheses covering these areas of virus research are practically never scientifically verified with appropriate controls. Instead, they are established by “consensus.” This is then rapidly reshaped into a dogma, efficiently perpetuated in a quasi-religious manner by the media, including ensuring that research funding is restricted to projects supporting the dogma, excluding research into alternative hypotheses. An important tool to keep dissenting voices out of the debate is censorship at various levels ranging from the popular media to scientific publications.
We haven’t learnt well from past experiences. There are still many unanswered questions on the causes of the 1918 Spanish flu epidemic, and on the role of viruses in post-WWII polio (DDT neurotoxicity?). These modern epidemics should have opened our minds to more
critical analyses. Pasteur and Koch had solidly constructed an understanding of infection applicable to many bacterial, contagious diseases. But this was before the first viruses were actually discovered. Transposing the principles of bacterial infections to viruses was, of course, very tempting but should not have been done without giving parallel attention to the innumerable risk factors in our toxic environment; to the toxicity of many drugs, and to some nutritional deficiencies.
Cancer research had similar problems. The hypothesis that cancer might be caused by viruses was formulated in 1903, more than one century ago. Even today it has never been convincingly demonstrated. Most of the experimental laboratory studies by virus-hunters
have been based on the use of inbred mice inbred implying a totally unnatural genetic background. Were these mice appropriate models for the study of human cancer? (we are far from being inbred!) True, these mice made possible the isolation and purification of “RNA
tumor viruses,” later renamed “retroviruses” and well characterized by electron microscopy.
But are these viral particles simply associated with the murine tumors, or are they truly the culprit of malignant transformation? Are these particles real exogenous infective particles, or endogenous defective viruses hidden in our chromosomes? The question is still debatable.
What is certain is that viral particles similar to those readily recognized in cancerous and leukemic mice have never been seen nor isolated in human cancers. Of mice and men…
However, by the time this became clear, in the late 1960s, viral oncology had achieved a dogmatic, quasi-religious status. If viral particles cannot be seen by electron microscopy in human cancers, the problem was with electron microscopy, not with the dogma of viral
oncology! This was the time molecular biology was taking a totally dominant posture in viral research. “Molecular markers” for retroviruses were therefore invented (reverse transcriptase
for example) and substituted most conveniently for the absent viral particles, hopefully salvaging the central dogma of viral oncology. This permitted the viral hypothesis to survive for another ten years, until the late 1970s, with the help of increasingly generous support
from funding agencies and from pharmaceutical companies. However by 1980 the failure of this line of research was becoming embarrassingly evident, and the closing of some viral oncology laboratories would have been inevitable, except that…
Except what? Virus cancer research would have crashed to a halt except that, in 1981, five cases of severe immune deficiencies were described by a Los Angeles physician, all among homosexual men who were also all sniffing amyl nitrite, were all abusing other drugs,
abusing antibiotics, and probably suffering from malnutrition and STDs (sexually transmitted diseases). It would have been logical to hypothesize that these severe cases of immune deficiency had multiple toxic origins. This would have amounted to incrimination of these
Unfortunately, such discrimination was, politically, totally unacceptable. Therefore, another hypothesis had to be found—these patients were suffering from a contagious disease caused by a new…retrovirus! Scientific data in support of this hypothesis was and, amazingly enough, still is totally missing. That did not matter, and instantaneous and passionate interest of cancer virus researchers and institutions erupted immediately. This was salvation for the
viral laboratories where AIDS now became, almost overnight, the main focus of research. It generated huge financial support from Big Pharma, more budget for the CDC and NIH, and nobody had to worry about the life style of the patients who became at once the innocent
victims of this horrible virus, soon labeled as HIV.
Twenty-five years later, the HIV/AIDS hypothesis has totally failed to achieve three major goals in spite of the huge research funding exclusively directed to projects based on it. No AIDS cure has ever been found; no verifiable epidemiological predictions have ever been
made; and no HIV vaccine has ever been successfully prepared. Instead, highly toxic (but not curative) drugs have been most irresponsibly used, with frequent, lethal side effects. Yet
not a single HIV particle has ever been observed by electron microscopy in the blood of patients supposedly having a high viral load! So what? All the most important newspapers and magazine have displayed attractive computerized, colorful images of HIV that all
originate from laboratory cell cultures, but never from even a single AIDS patient. Despite this stunning omission the HIV/AIDS dogma is still solidly entrenched. Tens of thousands of researchers, and hundreds of major pharmaceutical companies continue to make huge
profits based on the HIV hypothesis. And not one single AIDS patient has ever been cured…
Yes, HIV/AIDS is emblematic of the corruption of virus research that is remarkably and tragically documented in this book.
Research programs on Hepatitis C, BSE, SARS, Avian flu and current vaccination policies all developed along the same logic, that of maximizing financial profits. Whenever we try to understand how some highly questionable therapeutic policies have been recommended at
the highest levels of public health authorities (WHO, CDC, RKI etc.), we frequently discover either embarrassing conflicts of interests, or the lack of essential control experiments, and always the strict rejection of any open debate with authoritative scientists presenting
dissident views of the pathological processes. Manipulations of statistics, falsifications of clinical trials, dodging of drug toxicity tests have all been repeatedly documented. All have been swiftly covered up, and none have been able to, so far, disturb the cynical logic of
today’s virus research business. The cover-up of the neurotoxicity of the mercury containing preservative thimerosal as a highly probable cause of autism among vaccinated children apparently reached the highest levels of the US government… (see article “Deadly
Immunity” from Robert F. Kennedy Jr. in chapter 8)
Virus Mania is a social disease of our highly developed society. To cure it will require conquering fear, fear being the most deadly contagious virus, most efficiently transmitted by the media.
Errare humanum est sed diabolicum preservare… (to err is human, but to preserve an error is diabolic).
Etienne de Harven, MD
Professor Emeritus of Pathology at the University of Toronto and
Member of the Sloan Kettering Institute for Cancer Research, New York (1956 - 1981)
Member of Thabo Mbeki’s IDS Advisory Panel of South Africa
President of Rethinking AIDS (http://www.rethinkaids.net)